GlaxoSmithKline
GSK
#209
Rank
C$136.79 B
Marketcap
C$67.77
Share price
-0.82%
Change (1 day)
44.73%
Change (1 year)

GlaxoSmithKline (GSK) - Net assets

Net assets on the balance sheet as of September 2025 : C$29.54 Billion

According to GlaxoSmithKline's latest financial reports the company has C$29.54 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$23.56 B8.99%
2023-12-31$C$21.62 B30.45%
2022-12-31$C$16.57 B-54.86%
2021-12-31$C$36.71 B1.52%
2020-12-31$C$36.16 B15.03%
2019-12-31$C$31.43 B395.15%
2018-12-31$C$6.34 B7.1%
2017-12-31$C$5.92 B-27.96%
2016-12-31$C$8.22 B-54.91%
2015-12-31$C$18.25 B104.65%
2014-12-31$C$8.91 B-34.99%
2013-12-31$C$13.71 B26.68%
2012-12-31$C$10.82 B-22.41%
2011-12-31$C$13.95 B-7.19%
2010-12-31$C$15.03 B-17.78%
2009-12-31$C$18.29 B23.39%
2008-12-31$C$14.82 B-24.6%
2007-12-31$C$19.65 B-10.63%
2006-12-31$C$21.99 B44.75%
2005-12-31$C$15.19 B7.19%
2004-12-31$C$14.17 B-27.74%
2003-12-31$C$19.61 B4.86%
2002-12-31$C$18.70 B-3.54%
2001-12-31$C$19.39 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
C$64.14 B 117.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$129.89 B 339.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$72.42 B 145.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$62.43 B 111.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$120.40 B 307.52%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
C$10.12 B-65.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
C$0.74 B-97.48%๐Ÿ‡บ๐Ÿ‡ธ USA